SPATS2, negatively regulated by miR-145-5p, promotes hepatocellular carcinoma progression through regulating cell cycle
-
Published:2020-10
Issue:10
Volume:11
Page:
-
ISSN:2041-4889
-
Container-title:Cell Death & Disease
-
language:en
-
Short-container-title:Cell Death Dis
Author:
Dong Gang, Zhang Shanshan, Shen Shen, Sun Lulu, Wang XuemeiORCID, Wang Haiyu, Wu Jie, Liu Tingting, Wang Chaoyan, Wang Huanbin, Lu Taiying, Rao Benchen, Ren Zhigang
Abstract
AbstractSpermatogenesis associated serine rich 2 (SPATS2) has been reported to contribute to the tumorigenesis of multiple malignancies. The molecular function of SPATS2 in hepatocellular carcinoma (HCC) is still not fully understood. In this study, we aimed to investigate the expression pattern and function roles of SPATS2 in HCC. The regulation of SPATS2 expression was also explored. We found that SPATS2 was highly expressed in HCC tissues in comparison with that in adjacent normal tissues. High expression of SPATS2 was associated with vascular invasion, advanced TNM stages, tumor multiplicity, and poor survival. Functionally, SPATS2 was found to promote the proliferation and metastasis of HCC cells both in vitro and in vivo, while knockdown of SPATS2 enhanced apoptosis and G1 arrest of HCC cells in vitro. Mechanistically, bioinformatics analysis revealed that MiR-145-5p directly targeted SPATS2 and functional rescue experiments verified that MiR-145-5p overexpression could abolish the effect of SPATS2 on the regulation of HCC malignant phenotype. Taken together, our findings suggest that SPATS2 functions as an oncogene in HCC. The MiR-145-5p/SPATS2 axis provides a novel mechanism underlying HCC progression and may serve as a potential therapeutic target for HCC.
Publisher
Springer Science and Business Media LLC
Subject
Cancer Research,Cell Biology,Cellular and Molecular Neuroscience,Immunology
Reference34 articles.
1. Siegel, R. L., Miller, K. D. & Jemal, A. Cancer statistics, 2018. CA: Cancer J. Clinicians 68, 7–30 (2018). 2. Venook, A. P., Papandreou, C., Furuse, J. & de Guevara, L. L. The incidence and epidemiology of hepatocellular carcinoma: a global and regional perspective. Oncologist 15, 5–13 (2010). 3. Malek, N. P., Schmidt, S., Huber, P., Manns, M. P. & Greten, T. F. The diagnosis and treatment of hepatocellular carcinoma. Dtsch. Arzteblatt Int. 111, 101–106 (2014). 4. Senoo, M., Hoshino, S., Mochida, N., Matsumura, Y. & Habu, S. Identification of a novel protein p59(scr), which is expressed at specific stages of mouse spermatogenesis. Biochem. Biophys. Res. Commun. 292, 992–998 (2002). 5. Seki, K. et al. Microarray analysis of bisphenol A-induced changes in gene expression in human oral epithelial cells. Acta Biochim. Biophys. Sin. 39, 879–884 (2007).
Cited by
25 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|